SYNERGIE : 2024 REVENUES


Werte in diesem Artikel
Aktien

27.80 EUR 0.00 EUR 0.0 %

PRESS RELEASE | January 29th 2025, 5.45pm

2024 REVENUES

Thanks to its strategy of diversification, Synergie continues to grow amid an uncertain economic environment and in 2024 posted sales of €3.2 billion, up +2.4%

Werbung

  in € mQ4 2024Q4 2023% VarianceFY 2024FY 2023% Variance
  International502483+3.9%1,9191,816+5.7%
  France317320-0.9%1,2651,293-2.1%
  Total819803+2.0%3,1843,109+2.4%

Despite a challenging market, SYNERGIE continued to grow over the year, setting a new sales record at €3,184 million, up +2.4% on the 2023 financial year (+0.9% on a like-for-like basis). This performance was achieved with  the contribution of all the geographical regions in which the Group operates.

International sales (+5,7%), which account for 60.3% of the Group's business, were driven by an organic growth of +3.0% and the input of acquisitions which generated €44m over the year. Growth in Northern and Eastern Europe (+3.8%) remained positive despite the economic slowdown in these countries thanks to an outstanding performance of our Belgian subsidiary in a declining market. Southern Europe continued to grow with a remarkable commercial dynamics (+5.7%) of our Italian and Spanish operations.

Werbung

SYNERGIE's performance in France, with sales of €1,265 million (39.7% of the consolidated total), down -2.1%, should be seen in the context of the national market which is in sharp decline due mainly to political uncertainties and the economic difficulties of companies.

With a strong financial structure, SYNERGIE has the necessary resources to pursue actively its growth in an economic environment which, while more complex, is also a source of opportunities.

NEXT MEETING

• Publication of 2024 results on Wednesday April 2nd, 2025 after market closing

Werbung

Attachment


Werbung

Synergie Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Synergie nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"

Keine Analysen gefunden.

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.